Trial Profile
An Expanded Access Program of Avastin in Patients With Metastatic Cancer of Colon or Rectum - Brazilian Extension Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Dec 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Registrational
- Sponsors Roche
- 07 Aug 2010 New trial record